Your browser doesn't support javascript.
loading
Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction.
Hussain, Yasin; Drill, Esther; Dang, Chau T; Liu, Jennifer E; Steingart, Richard M; Yu, Anthony F.
Afiliação
  • Hussain Y; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Drill E; Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Dang CT; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Liu JE; Department of Medicine, Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Steingart RM; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Yu AF; Department of Medicine, Cardiology Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA.
Breast Cancer Res Treat ; 175(1): 239-246, 2019 May.
Article em En | MEDLINE | ID: mdl-30721443

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Volume Sistólico / Neoplasias da Mama / Trastuzumab / Antineoplásicos Imunológicos / Cardiopatias Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Volume Sistólico / Neoplasias da Mama / Trastuzumab / Antineoplásicos Imunológicos / Cardiopatias Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2019 Tipo de documento: Article